MedPath

Pilot Study for Speculum Free Cervical Cancer Screening

Not Applicable
Recruiting
Conditions
Cervical Cancer
Registration Number
NCT04107181
Lead Sponsor
Duke University
Brief Summary

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Detailed Description

This project is to assess if the introducer, "calla", can be used in place of a speculum during a routine Pap smear. For the patient arm, the introducer will be used in conjunction with standard of care procedures. The healthy volunteer arm will include taking the introducer home for a week to determine if each person can find their cervix without the help of a physician. As well as completing surveys on ease of use and demographics related to their medial history.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
305
Inclusion Criteria

Healthy female

  • Aged 21-65 years
  • Have had a pelvic exam
  • Have conversational proficiency in English
  • Highest level of education attained
Exclusion Criteria
  • Pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Assessment of introducerUp to 1 week (at time of pap smear for patients and up to 1 week for healthy volunteers)

We will conduct interviews/surveys to determine if subjects enrolled prefer introducer over SOC speculum

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Duke University

🇺🇸

Durham, North Carolina, United States

Duke University
🇺🇸Durham, North Carolina, United States
Nimmi Ramanujam, PhD
Contact
nimmi@duke.edu
Jennifer Gallagher, BA
Contact
9199701551
jennifer.gallagher@duke.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.